DIA DiaSorin S.p.A.

BIT · IT · Healthcare · Diagnostics & Research · int.diasorin.com

75.92EUR+1.36%Mkt Cap: 4.08B $P/E: 27.91Today

DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiag…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc Common Stock

$242.11BUSDP/E 35.5

DHR

Danaher Corporation Common Stock

$150.48BUSDP/E 38.2

NTRA

Natera, Inc. - Common Stock

Agilent Technologies, Inc. Common Stock

$47.30BUSDP/E 33.1

IQV

IQVIA Holdings, Inc. Common Stock

$42.50BUSDP/E 32.2

WAT

Waters Corporation Common Stock

$41.75BUSDP/E 107.4

ILMN

Illumina, Inc. - Common Stock

$41.23BUSDP/E 50.8

IDXX

IDEXX Laboratories, Inc. - Common Stock

$40.89BUSDP/E 36.4

MTD

Mettler-Toledo International, Inc. Common Stock

$29.78BUSDP/E 34.0

DGX

Quest Diagnostics Incorporated Common Stock

$25.75BUSDP/E 25.0

Labcorp Holdings Inc. Common Stock

$25.02BUSDP/E 25.5

Guardant Health, Inc. - Common Stock

$23.86BUSD

RVTY

Revvity, Inc. Common Stock

$16.91BUSDP/E 72.5

MEDP

Medpace Holdings, Inc. - Common Stock

$16.73BUSDP/E 35.2

ERF

Eurofins Scientific SE

$14.05BUSDP/E 26.2

CRL

Charles River Laboratories International, Inc. Common Stock

$13.85BUSD

ICLR

ICON plc - Ordinary Shares

Qiagen N.V. Common Shares

$9.24BUSDP/E 22.7

Key Statistics

Company

Market Cap4.08B USD

Enterprise Value4.94B USD

Revenue (TTM)1.28B USD

Gross Profit840.73M USD

Net Income (TTM)169.16M USD

Revenue/Share22.98 EUR

Last Price75.92 EUR

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees3.3K

CountryIT

SectorHealthcare

IndustryDiagnostics & Research

ISINIT0003492391

Valuation

P/E (Trailing)27.91

P/E (Forward)17.32

PEG1.59

EV/EBITDA13.29

EV/Revenue3.86

P/S3.15

P/B2.60

EPS (TTM)2.72

EPS (Forward)4.32

52W Range

52.3484% of range80.38

52W High80.38 EUR

52W Low52.34 EUR

Profitability

Gross Margin64.72%

Oper. Margin22.38%

EBITDA Margin29.04%

Profit Margin13.02%

ROE9.82%

ROA5.42%

Growth

Revenue Growth2.70%

Earnings Growth6.60%

Cash Flow & Leverage

Operating CF372.57M USD

CapEx (TTM)149.65M USD

FCF Margin11.27%

FCF Yield3.54%

Net Debt917.80M USD

Net Debt/EBITDA2.47

Balance Sheet

Debt/Equity0.50

Current Ratio1.79

Quick Ratio0.85

Book Value/Sh28.76 EUR

Cash/Share2.44 EUR

Dividends

Fwd Div Rate1.30 EUR

Trail. Div Rate1.30 EUR

Div. Yield1.74%

5Y Avg Yield1.08%

Payout Ratio47.79%

Ex-Div DateMay 18, 2026

Pay Date—

Analyst Consensus

Rating2.9 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)72.81 EUR

Upside (mean)-4.1%

Target Range55.00 EUR – 90.00 EUR

55.00-4.1% to mean90.00

# Analysts14

Ownership

Shares Out.49.44M

Float14.96M

Insiders57.56%

Institutions13.69%

Technical

SMA 5075.01 (+1.2%)

SMA 20069.30 (+9.6%)

Beta0.70

S&P 52W Chg14.58%

Avg Vol (30d)200.67K

Avg Vol (10d)190.78K

Technical Indicators

RSI (14)46.4

MACD0.5849

MACD Signal0.9009

MACD Hist.-0.3160

BB Upper80.01 EUR

BB Middle75.90 EUR

BB Lower71.79 EUR

BB Width10.82%

ATR (14)1.930 EUR

Vol Ratio (20d)1.01x